Technology | December 13, 2011

Ziltron Unveils Technology to Improve Radiological Diagnosis Accuracy

December 13, 2011 — At RSNA 2011, Ziltron will launch its Web-based Perform & Director Product Suite to measure, analyze and improve the diagnostic capability, quality and performance of radiology professionals. The company, based in San Diego, Calif. with a European base in Limerick, Ireland, delivers observer performance and digital imaging diagnostics.

Traditionally, performance-testing and quality assurance for the radiology industry has lacked standards-based technology and analytics to gauge the proficiency of reading examinations among radiologists. This has been true both for training and in the field; accuracy of test and examinations has been a subjective exercise until now.

The company’s suite of training, educational and accreditation solutions significantly improves digital imaging diagnostic accuracy. Combining high-quality image viewing, real-time data capture and reporting facilities, the technology delivers accurate statistical feedback on performance. The company’s tools are ideal for accreditation, quality assurance, certification and CME programs.

One of Ziltron’s early customers is BreastScreen Australia (BSA), which aims to reduce morbidity and mortality from breast cancer in Australia by the early detection of breast cancer. The BreastScreen Reader Assessment Strategy (BREAST) is a resource by which BreastScreen Australia may continue to meet these aims.

The strategy is based on digital screen reading test sets by Ziltron designed to assess performance of screen readers and provide immediate feedback to individual readers and BreastScreen Services.

“Ziltron has the proven expertise and knowledge to support national and international bodies to transform the education and performance of breast imaging,” said Patrick Brennan, professor of medical imaging, University of Sydney, and project manager for Breast Australia. “Their tools are effective, modern and adaptive and should suit the needs of clinicians and scientists in a variety of domains.”

Ziltron’s assets include:

· Diagnostic assessment: The company’s digital imaging diagnostics suite allows users to diagnose confirmed cases; the technology then measures the ability of the user to make a correct diagnosis, and compare that diagnosis to the universe of others who have taken the same test.

· User observation: Statistical algorithms measure all elements of the user experience including detailed data on the user’s interaction with the system during the test process. The system monitors and measures Graphical User Interface (GUI) tools such as zooming, contract/brightness control and image navigation; it also records the duration of individual case selections and the overall test set. This detailed data enables administrators and researchers to evaluate granular user observation patterns that can be used in future tests and improve the test sets and diagnostic competence of users.

· Advanced statistical analysis: Data is processed in real time, and users can receive a comprehensive set of statistical results upon completion of the test set. Results are based on statistical analysis important to digital imaging diagnosis including: receiver operating characteristic (ROC), sensitivity, specificity, location sensitivity, and true/false positives and negatives. Groups, institutions and peer-to-peer analysis and reports are available; performance comparisons are also available in graphical format using the “Heat Map” applications.

The Perform & Director Product Suite is a performance, quality assurance and educational tool to significantly improve the knowledge of professionals whose area of expertise involves digital imaging diagnosis. The product is available in myriad formats including web-based, PC and Mac applications, iPad and smartphones.

Ziltron will display in booth #1108 at RSNA 2011.

For more information: www.ziltron.com

Related Content

News | Digital Radiography (DR) | January 22, 2018
Canon Medical Systems Europe B.V. announced the change of ownership of DelftHold B.V. following its acquisition of the...
Technology | PACS | January 22, 2018
QualiTest Group recently announced its improved Virtual Radiology Environment (VRE) testing solution for picture...
National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
Videos | Artificial Intelligence | January 18, 2018
ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Soci
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Sponsored Content | Videos | Enterprise Imaging | January 17, 2018
Mitchell Goldburgh, global solutions manager for enterprise imaging and analytics manager for NTT Data Services, form
Sponsored Content | Videos | Enterprise Imaging | January 16, 2018
Built on an over 25-year pioneering legacy in the advanced visualization industry, Vital continues to expand on three
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...
News | Clinical Decision Support | January 12, 2018
January 12, 2018 — GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop an
The artificial intelligence (AI) smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices.

The AI smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices. The size of the bleed volume indicates the urgency and type of treatment required.

Feature | Artificial Intelligence | January 10, 2018 | Greg Freiherr
Exhibitors at the 2017 Radiological Society of North American (RSNA) meeting rode the...
Overlay Init